MedTrace Logo

Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye

NCT01404364 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2011-07-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of intravitreal triamcinolone and retrobulbar chlorpromazine as alternatives in the management of ocular pain in blind eyes.

Conditions

  • Blind Painful Eye
  • Refractory Glaucoma
  • Control of Pain Through Drug Injection

Interventions

DRUG

Triamcinolone

0,3mL intravitreal injection of Triamcinolone, single dose

DRUG

Chlorpromazine

2,5mL Chlorpromazine retrobulbar injection, single dose

Sponsors & Collaborators

  • Hospital Governador Celso Ramos

    lead OTHER

Principal Investigators

  • Deborah C Ribas, MD · Hospital Governador Celso Ramos

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01404364 on ClinicalTrials.gov